EGFR and non-small cell lung carcinoma: Moreover, the CNVs of NSCLC-driven genes EGFR, KRAS, and TP53 were assessed and the results were 13.43%, 10.69%, and 6.53% (Table 1, Figure 2(a)), respectively.